Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-05-01
1993-01-12
Lacey, David L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530395, 435 692, A61K 3702
Patent
active
051790815
ABSTRACT:
A polypeptide having an amino acid sequence as shown in FIG. 1 and its preparation method are disclosed. A DNA fragment capable of coding CPBII polypeptide (human placenta-derived coagulation inhibitor) is first obtained from the human placental cDNA library by using a CPBII-specific antibody as a probe. Then, microorganism cells are transformed by the use of a recombinant plasmid incorporated with the DNA fragment, allowing the resultant transformant to express the CPBII gene, to finally obtain a CPBII-like polypeptide. The polypeptide of this invention exhibits strong anticoagulation activities, and useful for an active component of anticoagulation medicines and preventin in vivo blood coagulation.
REFERENCES:
patent: 4873222 (1989-10-01), Arai
Crompton et al "Primary Structure of the human, membrane-associated Ca.sup.2+ . . . "EMBO v. 7, No. 1 pp. 21-27 Jan. 1988.
Iwasaki Akio
Saino Yushi
Suda Makoto
Kowa Co. Ltd.
Lacey David L.
Ossanna Nina
LandOfFree
Method of treatment using an anticoagulant polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment using an anticoagulant polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment using an anticoagulant polypeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220243